Skip to main content

Year: 2024

Heritage Commerce Corp Reports Client Deposit Growth of 6% in the Third Quarter of 2024

SAN JOSE, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) — Heritage Commerce Corp (Nasdaq: HTBK), (the “Company”), the holding company for Heritage Bank of Commerce (the “Bank”), today announced that its third quarter 2024 net income was $10.5 million, or $0.17 per average diluted common share, compared to $9.2 million, or $0.15 per average diluted common share, for the second quarter of 2024, and $15.8 million, or $0.26 per average diluted common share, for the third quarter of 2023. For the nine months ended September 30, 2024, net income was $29.9 million, or $0.49 per average diluted common share, compared to $51.1 million, or $0.83 per average diluted common share, for the nine months ended September 30, 2023. All data are unaudited. “The highlight of the third quarter of 2024 was significant deposit growth from our clients throughout...

Continue reading

CarnoSyn® Brands Announces New U.S. Distribution Agreement With B&D Nutritional Ingredients

CARLSBAD, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) — CarnoSyn® Brands and parent company Natural Alternatives International, Inc. (“NAI”) (Nasdaq: NAII), are pleased to announce a new distribution partnership with B&D Nutritional Ingredients, Inc., a renowned raw material distributor in the dietary supplement industry since 1993. This strategic partnership took effect on October 1st, 2024. Under the terms of the agreement, B&D will distribute NAI’s newly introduced carnosine booster, TriBsyn™, to the U.S.-based nutritional dietary supplement, functional food, and beverage market segments. Carnosine, which is naturally produced in the body through the synthesizing of beta-alanine and histidine, is a powerful antioxidant that has been shown to provide health benefits for muscle, brain, heart, bone, and overall systemic...

Continue reading

Federal Home Loan Bank of San Francisco Announces Third Quarter 2024 Operating Results

SAN FRANCISCO, Oct. 24, 2024 (GLOBE NEWSWIRE) — The Federal Home Loan Bank of San Francisco (Bank) today announced its unaudited third quarter 2024 operating results. Net income for the third quarter of 2024 was $102 million, a decrease of $1 million compared with net income of $103 million for the third quarter of 2023.  “We continue to manage a solid balance sheet, strong liquidity position, and a steadfast commitment to investing in innovative and impactful programs that meet our public mission and expand affordable housing and economic opportunity throughout our district,” said Alanna McCargo, president and chief executive officer of the Bank. “In the third quarter of 2024, we awarded Access to Housing and Economic Assistance for Development (AHEAD) Program grants, which provided $7.3 million in funding to 84 organizations...

Continue reading

Entourage Health Increases Senior Secured Credit Facility

TORONTO, Oct. 24, 2024 (GLOBE NEWSWIRE) — Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE: 4WE) (“Entourage” or the “Company“), a Canadian producer and distributor of award-winning cannabis products, confirmed today it has signed an amendment (the “Amendment“) to its senior secured amended and restated credit facility entered into on January 31, 2023 (the “Credit Facility“) with an affiliate of the LiUNA Pension Fund of Central and Eastern Canada (“LPF“). The Amendment provides an increase to the Credit Facility by an addition of approximately $2,500,000 (which funds have been advanced to the Company in a single draw). No further changes were made in respect of the Credit Facility. As previously announced, the Company has received a forbearance letter from LPF...

Continue reading

Nyrstar NV provides an update with regards to the Mechelen criminal investigation

Regulated Information Nyrstar NV provides an update with regards to the Mechelen criminal investigation 24 October 2024 at 23.30 CEST Nyrstar NV (the “Company”) was notified today that, on 24 October 2024, the council chamber of the court of first instance in Mechelen decided to discharge the investigating judge in Mechelen of the criminal investigation into Nyrstar NV, with a view to transferring the criminal file to the investigating judge of the judicial investigation in Antwerp. The Company continues to provide its full cooperation with the ongoing criminal investigation in Antwerp. About Nyrstar NV The Company is incorporated in Belgium and listed on Euronext Brussels under the symbol NYR. For further information please visit the Nyrstar NV website: www.nyrstarnv.be For further information contact: Company Secretary –...

Continue reading

Acquisition of Common Shares of Yorbeau Resources Inc. by Henri Gélinas, Chairman

MONTREAL, Oct. 24, 2024 (GLOBE NEWSWIRE) — On October 23, 2024, Henri Gélinas, Chairman of the board of directors of Yorbeau Resources Inc. (“Yorbeau”) (TSX: YRB), acquired 1,200,000 class A common shares of Yorbeau (“Common Shares”). Immediately prior to acquiring the 1,200,000 Common Shares, Mr. Gélinas had beneficial ownership of, or control or direction over, 45,424,115 Common Shares and 500,000 exercisable options to purchase Common Shares, which represented, in the aggregate, approximately 9.9% of the issued and outstanding Common Shares of Yorbeau on a partially diluted basis. The 1,200,000 acquired Common Shares were acquired through the facilities of the Toronto Stock Exchange at a price of C$0.045 per Common Share and an aggregate purchase price of C$54,000. Immediately following the acquisition of the 1,200,000 Common...

Continue reading

Dentsply Sirona Provides Update on Byte Aligner Products

Voluntarily Suspends Sales and Marketing of Byte Aligners and Impression Kits Provides Select Preliminary Third Quarter 2024 Results CHARLOTTE, N.C., Oct. 24, 2024 (GLOBE NEWSWIRE) — DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq: XRAY), today announced the voluntary suspension of sales and marketing of its Byte Aligners and Impression Kits while the Company conducts a review of certain regulatory requirements related to these products. The Company’s decision was made in consultation with the U.S. Food and Drug Administration (FDA). In connection with this review, and Dentsply Sirona’s proactive efforts to continuously improve its processes, the Company has suspended shipment and processing of new and recently placed orders for Byte Aligners and Impression Kits. The Company holds itself to the highest...

Continue reading

Aurora Spine Corporation Announces Third Quarter 2024 Financial Results

– Company reports record revenue and net income – – Company to host conference call on Monday, October 28th at 11am ET/8am PT – NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES CARLSBAD, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in spine and interventional spine technology that improves spinal surgery outcomes, today announced its financial results for third quarter ended September 30, 2024. All figures are in U.S. dollars. Financial and Business HighlightsRecord quarterly revenue – The company recorded record quarterly revenue of $4,767,121 in Q3 2024 compared to Q3 2023 sales of $3,949,530, an improvement of 21% or $817,591.First quarter of positive net income – Q3 2024 had a...

Continue reading

Osisko Development Announces Oversubscribed and Fully Allocated Private Placement of Units

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES US$57.5 Million Brokered Private Placement (Including Exercise In Full of Option) Expected to close November 12, 2024 MONTREAL, Oct. 24, 2024 (GLOBE NEWSWIRE) — Osisko Development Corp. (NYSE: ODV, TSXV: ODV) (“Osisko Development” or the “Company“) is pleased to announce its private placement offering (“Offering“) of units of the Company (“Units“), announced on October 23, 2024, was oversubscribed and has been fully allocated. This Offering is expected to close on or about November 12, 2024, pursuant to which an aggregate of 31,944,700 Units are expected to be issued at a price of US$1.80 per Unit for gross proceeds of US$57,500,460 (including the exercise in full of the agents’ option). Sean...

Continue reading

Xtract One Announces Annual Fiscal 2024 Results

Record Performance as Full Year Revenue Surpasses $16 Million TORONTO, Oct. 24, 2024 (GLOBE NEWSWIRE) — Xtract One Technologies Inc. (TSX: XTRA) (OTCQX: XTRAF) (FRA: 0PL) (“Xtract One” or the “Company”) a leading technology-driven threat detection and security solution that prioritizes the patron access experience by leveraging artificial intelligence (AI), today announced its annual results for the year ended July 31, 2024. All information is in Canadian dollars unless otherwise indicated. “What a year it’s been! With record results across the board, we continue to make progress towards profitability through operational execution and higher top line growth,” stated Peter Evans, Chief Executive Officer of Xtract One. “Revenue for the year was $16.4 million – quadruple that of last year – while our combined backlog rose to $26.8...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.